pk/pd novel rhcg

Abstract The purpose of this first-in-human trial was to examine the safety, pharmacokinetics, and pharmacodynamics of a novel recombinant human chorionic gonadotropin (FE 999302, choriogonadotropin beta) to support its clinical development for various therapeutic indications. The single and...